SCHEMBL3362484

SCHEMBL3362484

CCCc1cc(O)cc(CCC)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 4/20 0.62
▸ CYP3A4 P08684 1/20 0.62
▸ CNR1 P21554 1/20 0.48
▸ CNR2 P34972 1/20 0.48
▸ LTA4H P09960 1/20 0.48
▸ PTPN1 P18031 1/20 0.45
▸ PTPN11 Q06124 1/20 0.45
▸ GPR84 Q9NQS5 1/20 0.44
▸ ACHE P22303 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2A Q12879 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL67909 0.94 PTGS2 (0.70) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL5168458 0.93 PTGS2 (0.56) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL5164535 0.91 PTGS2 (0.72) PTGS2CYP3A4GPR84ACHENPC1
SCHEMBL16527886 0.87 PTGS2 (0.56) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL3959592 0.85 PTGS2 (0.54) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL7700304 0.85 CNR1 (0.46) PTGS2CYP3A4CNR1CNR2GPR84
SCHEMBL5164118 0.85 PTGS2 (0.48) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL261561 0.84 PTGS2 (0.78) PTGS2CYP3A4GPR84ACHENPC1
SCHEMBL9512031 0.84 PTGS2 (0.52) PTGS2CYP3A4CNR1CNR2LTA4H
SCHEMBL70141 0.84 PTGS2 (0.52) PTGS2CYP3A4CNR1CNR2LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120118458-A Curable composition, resin, and cured product 东京应化工业株式会社 2025-06-10 — — CN disclosed
CN-119504380-A Liquid stabilizer for nitrate compound and preparation method thereof 南京理工大学 2025-02-25 — — CN disclosed
CN-113337170-A Curable composition, cured product, near-infrared absorption filter, and method for producing same 东京应化工业株式会社 2021-09-03 — — CN disclosed
US-20170137553-A1 GRAFT POLYMER, RESIN COLORED MATTER, METHOD FOR PRODUCING SAME, AND RESIN COMPOSITION CONTAINING RESIN COLORED MATTER WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2017-05-18 — — US disclosed
US-20170137553-A1 GRAFT POLYMER, RESIN COLORED MATTER, METHOD FOR PRODUCING SAME, AND RESIN COMPOSITION CONTAINING RESIN COLORED MATTER WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2017-05-18 — — US disclosed
US-20100209810-A1 POLYMER ELECTROLYTE COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-19 — — US disclosed
EP-2192597-A1 POLYMER ELECTROLYTE COMPOSITION Sumitomo Chemical Company, Limited (JP) 2010-06-02 — — EP disclosed
US-7514520-B2 Process for producing phosphonitrilic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-04-07 — — US disclosed
US-20080091050-A1 Process For Producing Phosphonitrilic Acid Ester ASAHI KASEI CHEMICAL CORPORATION (JP) 2008-04-17 — — US disclosed
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls BASF AKTIENGESELLSCHAFT (DE) 2007-06-07 — — US disclosed
US-5149834-A Anticholesterol agent and enzyme inhibitors, for curing arteriosclerosis FUJIREBIO INC. (JP) 1992-09-22 — — US disclosed
EP-0445827-A2 4-Hydroxytetrahydropyran-2-one derivatives useful as cholesterol and lipid reducing agents FUJIREBIO INC. (JP) 1991-09-11 — — EP disclosed
US-4284830-A Monohalogenation of substituted phenol PHILLIPS PETROLEUM CO. (US) 1981-08-18 — — US disclosed
US-4281204-A ALKYLATION, DECARBOXYLATION TO CYCLIZE FRITZSCHE DODGE & OLCOTT INC. (US) 1981-07-28 — — US disclosed
US-4261866-A PERFUMES AND PERFUME FIXATIVES FRITZSCHE DODGE & OLCOTT INC. (US) 1981-04-14 — — US disclosed
US-4203925-A Process for the production of spirodienones and spirocyclic ketones FRITZSCHE DODGE & OLCOTT INC. (US) 1980-05-20 — — US disclosed
EP-0006990-A1 N,N-bis-halogenomethyl-carbamic acid esters and process for their preparation BASF Aktiengesellschaft (DE) 1980-01-23 — — EP disclosed
US-4064179-A CHEMICAL INTERMEDIATES GENERAL ELECTRIC COMPANY (US) 1977-12-20 — — US disclosed
US-4060543-A Manufacture of 5-cyanovaleric acid and its esters BASF AKTIENGESELLSCHAFT (DT) 1977-11-29 — — US disclosed
US-3952063-A Process for the preparation of an organomercaptophenol from sulfur, a phenol, and an activated olefin or an epoxy compound GENERAL ELECTRIC COMPANY (US) 1976-04-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080091050-A1 Process For Producing Phosphonitrilic Acid Ester PHOSPHO1, GNPAT, SELENOI PTGS2 4037/4885CYP3A4 390/4885CNR1 3976/4885
US-20070129578-A1 Method for the production of 2,2'-dihydroxybiphenyls HAO2, DAO, DDO PTGS2 100/4885CYP3A4 351/4885CNR1 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback